Reuters provides insight into how Dutch pharmacies join backlash at expensive drugs by making their own

Reuters provided insight into how Dutch pharmacies are bypassing drug company products and making treatments for a handful of rare diseases themselves, as part of a protest against high drug prices. The Dutch market is small, with only hundreds of patients for the diseases in question, but the dispute is part of a growing global backlash against high drug prices from the United States and Canada to Japan, and campaigners said it was being closely watched by health experts elsewhere.